Medical Xpress September 2, 2024
European Society of Cardiology

A large randomized trial showed no significant differences to demonstrate that using artificial intelligence (AI) to aid clinical decision-making in assessing heart ultrasounds is as effective as current practice at identifying all-comers with suspected heart disease who may benefit from invasive investigation and treatment.

However, the findings being presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug—2 Sept), showed that AI improved decision making for less-experienced clinicians, and had promising results in certain important sub-groups that are clinically complex.

“Integration of AI into health care holds great promise as a tool to help diagnose faster and more accurately, allowing them to start treatment sooner,” said lead author Dr. Ross...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Conferences / Podcast, Physician, Provider, Technology, Trends
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article